Cargando…
Dual MGMT inactivation by promoter hypermethylation and loss of the long arm of chromosome 10 in glioblastoma
BACKGROUND: Epigenetic inactivation of O6‐methylguanine‐methyltransferase (MGMT) gene by methylation of its promoter is predictive of Temozolomid (TMZ) response in glioblastoma (GBM). MGMT is located on chromosome 10q26 and the loss of chromosome 10q is observed in 70% of GBMs. In this study, we ass...
Autores principales: | Richard, Sophie, Tachon, Gaëlle, Milin, Serge, Wager, Michel, Karayan‐Tapon, Lucie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476845/ https://www.ncbi.nlm.nih.gov/pubmed/32666673 http://dx.doi.org/10.1002/cam4.3217 |
Ejemplares similares
-
Crizotinib targets in glioblastoma stem cells
por: Junca, Audelaure, et al.
Publicado: (2017) -
Targeted RNA‐sequencing assays: a step forward compared to FISH and IHC techniques?
por: Tachon, Gaëlle, et al.
Publicado: (2019) -
Impact of STAT3 phosphorylation in glioblastoma stem cells radiosensitization and patient outcome
por: Masliantsev, Konstantin, et al.
Publicado: (2017) -
MEOX2 Transcription Factor Is Involved in Survival and Adhesion of Glioma Stem-like Cells
por: Tachon, Gaëlle, et al.
Publicado: (2021) -
Pathological and Molecular Characteristics of Colorectal Cancer with Brain Metastases
por: Roussille, Pauline, et al.
Publicado: (2018)